Re: New RVX Tweet
|
2
|
Resverlogix Corp.
|
Jul 31, 2020 01:31PM
|
Re: New RVX Publication in Atherosclerosis
|
8
|
Resverlogix Corp.
|
Jan 24, 2016 04:04PM
|
Re: New RVX Publication in Atherosclerosis
|
8
|
Resverlogix Corp.
|
Jan 23, 2016 11:24PM
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
4
|
Resverlogix Corp.
|
May 11, 2016 04:25PM
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
3
|
Resverlogix Corp.
|
May 11, 2016 09:02PM
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
3
|
Resverlogix Corp.
|
May 12, 2016 10:00AM
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
6
|
Resverlogix Corp.
|
May 12, 2016 11:17AM
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
5
|
Resverlogix Corp.
|
May 12, 2016 12:02PM
|
Re: New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
|
4
|
Resverlogix Corp.
|
Mar 03, 2021 02:29PM
|
Re: New publications
|
3
|
Resverlogix Corp.
|
Oct 09, 2015 10:16AM
|
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Resverlogix Corp.
|
Jun 13, 2016 05:10PM
|
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 11:46PM
|
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Zenith Epigenetics
|
Jun 14, 2016 07:25AM
|
Re: New publication on ASSURE results
|
5
|
Resverlogix Corp.
|
Aug 30, 2018 10:12PM
|
Re: New publication
|
6
|
Resverlogix Corp.
|
Sep 23, 2019 12:59PM
|
Re: New price level when they announce 250 MACE Events,...?
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 12:47PM
|
Re: New presentation on the website
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 10, 2020 08:22PM
|
Re: New presentation on the website
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 11, 2020 06:04PM
|
Re: New presentation on the website
|
4
|
BIOASIS TECHNOLOGIES INC
|
Apr 11, 2020 06:15PM
|
Re: New presentation
|
2
|
Resverlogix Corp.
|
Mar 21, 2017 11:50AM
|